Connor, Clark & Lunn Investment Management Ltd. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,388,330
-3.7%
93,329
-14.1%
0.02%
-12.0%
Q1 2023$4,557,779
+3.3%
108,622
-6.1%
0.02%0.0%
Q4 2022$4,411,463
+90.3%
115,665
+95.4%
0.02%
+66.7%
Q3 2022$2,318,000
+33.8%
59,183
+10.3%
0.02%
+36.4%
Q2 2022$1,733,000
+23.2%
53,643
+26.2%
0.01%
+57.1%
Q1 2022$1,407,000
-54.9%
42,503
-42.1%
0.01%
-53.3%
Q4 2021$3,121,000
+30.9%
73,377
+36.3%
0.02%
+25.0%
Q3 2021$2,385,000
+200.8%
53,833
+408.1%
0.01%
+200.0%
Q1 2021$793,000
+95.3%
10,596
+125.8%
0.00%
+100.0%
Q4 2020$406,0004,6920.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders